ՄԵԸՔ մանրամասներ
000 -LEADER |
fixed length control field |
01241cam a2200337 a 4500 |
001 - CONTROL NUMBER |
control field |
000548696 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
AM-YeNLA |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20190426133404.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
790104s1979 enka b 100 0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0080231950 |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
|
Transcribing agency |
|
Modifying agency |
DLC |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
W3 IN54R 7th 1978a v. 5 |
-- |
QV77 I59 1978n |
082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615/.78 |
Edition number |
19 |
111 2# - MAIN ENTRY--MEETING NAME |
Meeting name or jurisdiction name as entry element |
International Congress of Pharmacology |
Number of part/section/meeting |
(7th : |
Date of meeting |
1978 : |
Location of meeting |
Paris, France) |
245 10 - TITLE STATEMENT |
Title |
Neuropsychopharmacology : |
Remainder of title |
Proceedings of the 7th International Congress of Pharmacology, Paris, 1978 / |
Statement of responsibility, etc. |
Editor : C. Dumont. |
250 ## - EDITION STATEMENT |
Edition statement |
1st ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. |
Place of publication, distribution, etc. |
Oxford ; |
-- |
New York : |
Name of publisher, distributor, etc. |
Pergamon Press, |
Date of publication, distribution, etc. |
1979. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
viii, 275 p. : |
Other physical details |
ill. ; |
Dimensions |
26 cm. |
440 #0 - SERIES STATEMENT/ADDED ENTRY--TITLE |
Title |
Advances in pharmacology and therapeutics ; |
Volume/sequential designation |
Vol. 5 |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliogr. references and index. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Neuropsychopharmacology |
General subdivision |
Congresses |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Antidepressants |
General subdivision |
Congresses |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Dopamine |
General subdivision |
Congresses |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Psychopharmacology |
General subdivision |
Congresses |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Antidepressive agents |
General subdivision |
Therapeutic use |
-- |
Congresses |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Depression |
General subdivision |
Drug therapy |
-- |
Congresses |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Dopamine |
General subdivision |
Congresses |
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Receptors, Dophamine |
General subdivision |
Congresses |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Dumont, C. |